Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1990 Jan 6;300(6716):18–22. doi: 10.1136/bmj.300.6716.18

Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.

D C Rowe-Jones 1, A L Peel 1, R D Kingston 1, J F Shaw 1, C Teasdale 1, D S Cole 1
PMCID: PMC1661869  PMID: 2105115

Abstract

OBJECTIVE--To establish whether a single preoperative dose of cefotaxime plus metronidazole was as effective as a standard three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery. DESIGN--Prospective randomised allocation to one of two prophylactic antibiotic regimens in a parallel group trial. Group sequential analyses of each 250 patients were performed. SETTING--14 District general and teaching hospitals. PATIENTS--1018 Adults having colorectal operations were randomised, of whom 943 were evaluated. Demographic features, conditions requiring surgery, and operative procedures were similar in the two groups. Most patients had surgery for carcinoma of the colon or rectum. INTERVENTIONS--Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1.5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively. MAIN OUTCOME MEASURES--Development of surgical wound infection (as evidenced by the presence of pus), death, or discharge from hospital. RESULTS--Wound condition was scored on a five point scale on alternate days until discharge or for up to 20 days postoperatively. Wound infection rates were: group 1, 32/453 (7.1%; 95% confidence interval 4.7% to 9.4%); group 2, 33/454 (7.3%; 95% confidence interval 4.9% to 9.6%). Death rates (group 1: 26/470 (5.5%); group 2: 31/471 (6.6%], the incidence of postoperative complications, the median duration of hospital stay (12 days), and antibiotic tolerance were all similar in the two groups. Pooled data from groups 1 and 2 showed that wound infections were more frequent when minor faecal contamination had occurred at operation and when the duration of operation exceeded 90 minutes (greater than 90 min 11.2% of cases; less than 90 min 4.8%) and were associated with an extended hospital stay. CONCLUSIONS--A single preoperative dose of cefotaxime plus metronidazole is an efficacious as a three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery and has practical advantages in eliminating the need for postoperative antibiotics.

Full text

PDF
18

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burdon D. W., Keighley M. R. Ceftriaxone and metronidazole as single-dose prophylaxis in colorectal surgery. S Afr Med J. 1987 Jun 20;Suppl 2:15–18. [PubMed] [Google Scholar]
  2. Cann K. J., Watkins R. M., George C., Payne-James J., Crawfurd E., Rogers T. R. A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery. J Hosp Infect. 1988 Oct;12(3):207–214. doi: 10.1016/0195-6701(88)90008-4. [DOI] [PubMed] [Google Scholar]
  3. Colizza S., De Fazio S., Addari A., Grande R., Cucchiara G. Short-term prophylaxis with cefuroxime in colorectal surgery for cancer. J Surg Oncol. 1987 Aug;35(4):266–268. doi: 10.1002/jso.2930350412. [DOI] [PubMed] [Google Scholar]
  4. Cunliffe W. J., Carr N., Schofield P. F. Prophylactic metronidazole with and without cefuroxime in elective colorectal surgery. A prospective randomised double-blind study. J R Coll Surg Edinb. 1985 Apr;30(2):123–125. [PubMed] [Google Scholar]
  5. Danziger L., Hassan E. Antimicrobial prophylaxis of gastrointestinal surgical procedures and treatment of intraabdominal infections. Drug Intell Clin Pharm. 1987 May;21(5):406–416. doi: 10.1177/106002808702100502. [DOI] [PubMed] [Google Scholar]
  6. DiPiro J. T., Welage L. S., Levine B. A., Wing P. E., Stanfield J. A., Gaskill H. V., Scarfoni D. S., Schentag J. J., Bowden T. A., Jr, Williams J. S. Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgery. J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):71–77. doi: 10.1093/jac/23.suppl_d.71. [DOI] [PubMed] [Google Scholar]
  7. Diamond T., Mulholland C. K., Hanna W. A., Parks T. G. A prospective randomized trial to compare triple dose mezlocillin with triple dose cefuroxime plus metronidazole as prophylaxis in colorectal surgery. J Hosp Infect. 1988 Oct;12(3):215–219. doi: 10.1016/0195-6701(88)90009-6. [DOI] [PubMed] [Google Scholar]
  8. Donowitz G. R., Mandell G. L. Drug therapy. Beta-lactam antibiotics (2). N Engl J Med. 1988 Feb 25;318(8):490–500. doi: 10.1056/NEJM198802253180806. [DOI] [PubMed] [Google Scholar]
  9. Eykyn S. J., Jackson B. T., Lockhart-Mummery H. E., Phillips I. Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet. 1979 Oct 13;2(8146):761–764. doi: 10.1016/s0140-6736(79)92114-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fry D. E. Antibiotics in surgery. An overview. Am J Surg. 1988 May 31;155(5A):11–15. doi: 10.1016/s0002-9610(88)80206-x. [DOI] [PubMed] [Google Scholar]
  11. Fuchs P. C., Jones R. N., Barry A. L., Allen S. D., Ayers L. W., Pfaller M. Desacetylcefotaxime--another broad spectrum cephalosporin? J Antimicrob Chemother. 1989 Jan;23(1):165–167. doi: 10.1093/jac/23.1.165. [DOI] [PubMed] [Google Scholar]
  12. Haddock G., Hansell D. T., McArdle C. S. Survey of antibiotic prophylaxis in gastrointestinal surgery in Scotland--5 years on. J Hosp Infect. 1988 Apr;11(3):286–289. doi: 10.1016/0195-6701(88)90107-7. [DOI] [PubMed] [Google Scholar]
  13. Jagelman D. G., Fabian T. C., Nichols R. L., Stone H. H., Wilson S. E., Zellner S. R. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. Am J Surg. 1988 May 31;155(5A):71–76. doi: 10.1016/s0002-9610(88)80217-4. [DOI] [PubMed] [Google Scholar]
  14. Jones R. N., Wojeski W. V. Single-dose surgical prophylaxis using ticarcillin/clavulanic acid (Timentin): a prospective, randomized comparison with cefotaxime. Diagn Microbiol Infect Dis. 1987 Jul;7(3):219–223. doi: 10.1016/0732-8893(87)90009-5. [DOI] [PubMed] [Google Scholar]
  15. Keighley M. R., Arabi Y., Alexander-Williams J., Youngs D., Burdon D. W. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979 Apr 28;1(8122):894–897. doi: 10.1016/s0140-6736(79)91373-4. [DOI] [PubMed] [Google Scholar]
  16. Kingston R. D., Duthie J. Serious postoperative bleeding associated with a single intravenous dose of cefuroxime and metronidazole. J Hosp Infect. 1986 Jan;7(1):100–101. doi: 10.1016/0195-6701(86)90036-8. [DOI] [PubMed] [Google Scholar]
  17. Kingston R. D., Kiff R. S., Duthie J. S., Walsh S., Spicer A., Jeacock J. Comparison of two prophylactic single-dose intravenous antibiotic regimes in the treatment of patients undergoing elective colorectal surgery in a district general hospital. J R Coll Surg Edinb. 1989 Aug;34(4):208–211. [PubMed] [Google Scholar]
  18. Mittermayer H., Gross C., Brücke P. Single dose cefuroxime/metronidazole versus metronidazole alone in elective colorectal surgery. Am Surg. 1984 Aug;50(8):418–423. [PubMed] [Google Scholar]
  19. Rowe-Jones D. C., Cole D. S. Single dose mezlocillin versus three dose cefuroxime plus metronidazole for prophylaxis in large bowel surgery. J Hosp Infect. 1988 Aug;12(2):131–132. doi: 10.1016/0195-6701(88)90136-3. [DOI] [PubMed] [Google Scholar]
  20. Stubbs R. S., Griggs N. J., Kelleher J. P., Dickinson I. K., Moat N., Rimmer D. M. Single dose mezlocillin versus three dose cefuroxime plus metronidazole for the prophylaxis of wound infection after large bowel surgery. J Hosp Infect. 1987 May;9(3):285–290. doi: 10.1016/0195-6701(87)90126-5. [DOI] [PubMed] [Google Scholar]
  21. Whitehead J., Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics. 1983 Mar;39(1):227–236. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES